Leukemia Research
Volume 29, Issue 7 , Pages 793-802, July 2005

The tyrosine kinase inhibitors imatinib and AG957 reverse multidrug resistance in a chronic myelogenous leukemia cell line

  • Daniella Yeheskely-Hayon

      Affiliations

    • Department of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel
    • ,
  • Ronit Regev

      Affiliations

    • Department of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel
    • ,
  • Gera D. Eytan

      Affiliations

    • Department of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972 4 8293406; fax: +972 4 8225153.
    • ,
  • Eldad J. Dann

      Affiliations

    • Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Bruce Rappaport Faculty of Medicine, Haifa 31096, Israel

Received 4 March 2004; accepted 17 December 2004. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(05)00032-9

doi:10.1016/j.leukres.2004.12.007

Leukemia Research
Volume 29, Issue 7 , Pages 793-802, July 2005

Article Tools

* Image Usage & Resolution